The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK | MicrobiomeTrials← Back to trialsNCT07602803
The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK
CompletedOBSERVATIONAL
Trial Details
Start: 2023-01-01Est. Completion: 2026-04-01
Enrollment target: 300 participants Locations- Queen Elizabeth Hospital Birmingham, Birmingham, West Midlands, United Kingdom
Other microbiome trials you might be interested in
Eye Diseases HereditaryRetinal DiseaseAchromatopsiaBardet-Biedl SyndromeBassen-Kornzweig SyndromeBatten DiseaseBest DiseaseChoroidal DystrophyChoroideremiaCone DystrophyCone-Rod DystrophyCongenital Stationary Night BlindnessEnhanced S-Cone SyndromeFundus AlbipunctatusGoldmann-Favre SyndromeGyrate AtrophyJuvenile Macular DegenerationKearns-Sayre SyndromeLeber Congenital Amaurosis
Refsum Syndrome
Retinitis Pigmentosa
Retinitis Punctata Albescens
Retinoschisis
Rod-Cone Dystrophy
Rod Dystrophy
Rod Monochromacy
Stargardt Disease
Usher Syndrome
The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of t…
Columbia, United StatesEst. completion Jun 2037
CiliopathiesNephronophthisisSenior-Loken SyndromeJoubert SyndromeJeune SyndromeBardet-Biedl Syndrome
The purpose of the C'IL-LICO RICM study is to develop innovative and transformative diagnostic and prognostic for patien…
Paris, FranceCompleted Oct 29, 2024